Prot#COR-2017-01:A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open-label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Project: Research project

Project Details

StatusActive
Effective start/end date4/24/184/24/21

Funding

  • Chiltern International, Inc. (Prot#COR-2017-01)
  • Cortendo AB (publ) (Prot#COR-2017-01)